Eden vs Fifty 410 (2026): prices, structure, verdict
On tirzepatide, only Eden has a rankable figure: $408 a month all-in; Fifty 410↗ publishes no maintenance-dose tirzepatide figure we could capture (advertised start: $133), so a like-for-like number does not exist.
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
On semaglutide, only Eden has a rankable figure: $198 a month all-in; Fifty 410 does not offer semaglutide.
Eden
- Tirzepatide all-in
- $408/mo
- Semaglutide all-in
- $198/mo · flat
- 12-mo tirzepatide (best path)
- $4,896
- Membership
- $99/mo (inside figures)
- Shipping
- included
- Commitment
- membership auto-renews
- Cancellation
- membership auto-renews until cancelled
- Pharmacy
- not named
- States
- most states
- Insurance
- no
- Evidence
- source-verified · 2026-08-05
Fifty 410
- Tirzepatide all-in
- from $133 · no maintenance figure
- Semaglutide all-in
- not offered
- 12-mo tirzepatide (best path)
- —
- Membership
- none
- Shipping
- unknown
- Commitment
- unknown
- Cancellation
- not published
- Pharmacy
- not named
- States
- not published
- Insurance
- no
- Evidence
- source-verified · 2026-08-05
The two records, condensed
Eden: the record, condensed
Start with the load-bearing figure: $408 a month, all-in, is what Eden charges for tirzepatide at the 10 mg basis. Pricing steps with the dose here: from $348 at entry to $408 at the 10 mg basis. Multiply the wrong one of those by twelve and your budget is off by $720 a year, which is why every ranking on this site uses the larger number.
A required $99/month membership is part of the deal, and part of the figure above: $309 of medication plus $99 of platform equals the $408 that leaves your account. Judge the membership by what it includes, but compare on the total.
To place the number: #16 of 17 verified programs, with the floor $193/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $41 a month. A year at this figure: $4,896 monthly-billed.
Eden’s semaglutide program bills $198 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.
Inside that $198 sits a mandatory $99-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $99, and it is not a price anyone can actually pay, because the membership cannot be declined.
Context for that figure: it ranks #10 of 20 in the verified semaglutide index — $65/month above the floor (Oak Longevity, $133) — and sits $151 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $2,376.
Operationally at Eden: shipping included; commitment membership auto-renews; cancellation membership auto-renews until cancelled; pharmacy not publicly named — ask in writing before paying; states: most states; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Eden page · visit Eden ↗
Fifty 410: the record, condensed
On tirzepatide, Fifty 410 advertises from $133 — and publishes no maintenance-dose figure we could capture. A starter-only price cannot be annualized, cannot be ranked, and should be treated as the bottom of an unstated range: before enrolling on its strength, get the 10 mg price in writing, and if the program will not state it, price the program at its ceiling rather than its floor.
Operationally at Fifty 410: shipping unknown; commitment unknown; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Fifty 410 page · visit Fifty 410 ↗
Everything besides the price
Coverage: Eden publishes “most states”; Fifty 410 publishes “not published” — for anything short of an explicit 50-state claim, intake is the final word.
Neither names its pharmacy publicly — the single most useful disclosure in this category, missing on both sides; ask each, in writing, before paying either.
Exit terms: Eden — membership auto-renews; membership auto-renews until cancelled. Fifty 410 — unknown; not published.
Evidence: Eden source-verified (captured 2026-08-05); Fifty 410 source-verified (2026-08-05).
The pattern worth internalizing: in this market, structural honesty and price honesty travel together. Programs that publish pharmacies and state lists tend to publish real maintenance prices; programs that hide one usually hide the other.
Switching between Eden and Fifty 410
Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (Eden: membership auto-renews until cancelled; Fifty 410: not published) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.
Which one, for whom
Cheapest tirzepatide month-to-month: Eden ($408).
Cheapest 12-month path: Eden at $4,896 (monthly billing).
Cheapest semaglutide: Eden ($198).
Simplest billing: Fifty 410 — no membership; Eden's $99/mo membership recurs until cancelled.
Without a shared rankable price, the verdict rests entirely on the structural axes above — and on which of these two makes your remaining questions answerable in writing before money moves.
Verdicts are computed from the records above — recompute them from the dataset. Full profiles: Eden · Fifty 410.
Frequently asked
Which is cheaper, Eden or Fifty 410?
On tirzepatide, only Eden has a rankable figure: $408 a month all-in ; Fifty 410 publishes no maintenance-dose tirzepatide figure we could capture (advertised start: $133), so a like-for-like number does not exist. On semaglutide, only Eden has a rankable figure: $198 a month all-in ; Fifty 410 does not offer semaglutide.
Is there a membership fee at Eden or Fifty 410?
Eden: $99/month, mandatory and already included in the figures here. Fifty 410: none.
Where do these numbers come from?
From each provider's own published pages, captured 2026-08-05 (Eden) and 2026-08-05 (Fifty 410), normalized to the all-in maintenance basis and archived. Full records: the provider pages and the public dataset.
Is Eden or Fifty 410 dose-flat?
Eden: yes — the price holds across the titration ladder. Fifty 410: no — assume the advertised figure is a starter price until the maintenance number is stated. Flat pricing turns the advertised number into a ceiling; tiered pricing makes it a floor.
Can I check both Eden and Fifty 410 against their sources?
Yes — that is the design. Each record carries a capture date (2026-08-05 / 2026-08-05), a source link, and an archive link in the database; the figures on this page regenerate from those records, so any discrepancy you find is reportable and fixable sitewide in one pass.
What states do Eden and Fifty 410 serve?
Eden: most states. Fifty 410: not published. Telehealth availability rides on clinician licensure and pharmacy permits, so for anything short of an explicit 50-state claim the enrollment flow is the final word; the state-by-state index adds the known exceptions.
Is shipping included at Eden and Fifty 410?
Eden: included. Fifty 410: unknown. Cold-chain delivery is a real cost; programs that fold it into the all-in figure remove a checkout surprise, and any separate shipping line belongs in your comparison math before the prices above are treated as equivalent.
Which is more transparent, Eden or Fifty 410?
On the checkable axes: pharmacy named — Eden no, Fifty 410 no; state list — Eden published, Fifty 410 published; cancellation terms — Eden published, Fifty 410 published; evidence — source-verified vs source-verified. Disclosure predicts disclosure in this market, and the axis where one of these two goes quiet is usually where your intake questions should get loud.